MicroRNA-146a Serves as a Biomarker for Adverse Prognosis of ST-Segment Elevation Myocardial Infarction

MicroRNA-146a Serves as a Biomarker for Adverse Prognosis of ST-Segment Elevation Myocardial Infarction

Objective. This study is aimed at exploring the underlying molecular mechanisms of ST-segment elevation myocardial infarction (STEMI) and provides potential clinical prognostic biomarkers for STEMI. Methods. The GSE60993 dataset was downloaded from the GEO database, and the differentially expressed...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Shengjue Xiao, Tongneng Xue, Qinyuan Pan, Yue Hu, Qi Wu, Qiaozhi Liu, Xiaotong Wang, Ailin Liu, Jie Liu, Hong Zhu, Yufei Zhou, Defeng Pan
Formato: article
Lenguaje:EN
Publicado: Hindawi-Wiley 2021
Materias:
Therapeutics. Pharmacology
RM1-950
Diseases of the circulatory (Cardiovascular) system
RC666-701
Acceso en línea:https://doaj.org/article/9570007275a745c5a5bad34200d758d0
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Ejemplares similares